Oil & Gas Integrated
Compare Stocks
5 / 10Stock Comparison
IMO vs SU vs CVX vs CVE vs XOM
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Integrated
IMO vs SU vs CVX vs CVE vs XOM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Integrated |
| Market Cap | $62.57B | $75.67B | $364.18B | $53.60B | $620.85B |
| Revenue (TTM) | $47.04B | $52.01B | $184.43B | $49.40B | $323.90B |
| Net Income (TTM) | $3.27B | $6.33B | $12.30B | $4.64B | $28.84B |
| Gross Margin | 21.2% | 55.5% | 30.4% | 19.6% | 21.7% |
| Operating Margin | 9.0% | 27.4% | 9.0% | 14.0% | 10.5% |
| Forward P/E | 15.0x | 7.7x | 15.0x | 7.5x | 14.8x |
| Total Debt | $4.23B | $18.37B | $46.74B | $17.00B | $43.54B |
| Cash & Equiv. | $1.14B | $3.65B | $6.47B | $2.74B | $10.68B |
IMO vs SU vs CVX vs CVE vs XOM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Imperial Oil Limited (IMO) | 100 | 805.6 | +705.6% |
| Suncor Energy Inc. (SU) | 100 | 372.4 | +272.4% |
| Chevron Corporation (CVX) | 100 | 199.0 | +99.0% |
| Cenovus Energy Inc. (CVE) | 100 | 657.3 | +557.3% |
| Exxon Mobil Corpora… (XOM) | 100 | 322.2 | +222.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IMO vs SU vs CVX vs CVE vs XOM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IMO ranks third and is worth considering specifically for long-term compounding.
- 337.2% 10Y total return vs SU's 197.4%
- 8.1% ROA vs CVX's 4.2%, ROIC 12.3% vs 6.2%
SU is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth -3.5%, EPS growth 2.8%, 3Y rev CAGR -5.7%
- -3.5% revenue growth vs CVE's -14.0%
- 12.2% margin vs CVX's 6.7%
CVX is the clearest fit if your priority is income & stability.
- Dividend streak 8 yrs, beta -0.05, yield 3.8%
- 3.8% yield, 8-year raise streak, vs IMO's 1.6%
CVE carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.22, Low D/E 53.8%, current ratio 1.57x
- Beta 0.22, yield 2.0%, current ratio 1.57x
- Lower P/E (7.5x vs 14.8x)
- Beta 0.22 vs IMO's 0.25
Among these 5 stocks, XOM doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -3.5% revenue growth vs CVE's -14.0% | |
| Value | Lower P/E (7.5x vs 14.8x) | |
| Quality / Margins | 12.2% margin vs CVX's 6.7% | |
| Stability / Safety | Beta 0.22 vs IMO's 0.25 | |
| Dividends | 3.8% yield, 8-year raise streak, vs IMO's 1.6% | |
| Momentum (1Y) | +147.0% vs CVX's +39.5% | |
| Efficiency (ROA) | 8.1% ROA vs CVX's 4.2%, ROIC 12.3% vs 6.2% |
IMO vs SU vs CVX vs CVE vs XOM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IMO vs SU vs CVX vs CVE vs XOM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SU leads in 2 of 6 categories
IMO leads 1 • CVX leads 0 • CVE leads 0 • XOM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SU leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 6.9x IMO's $47.0B. SU is the more profitable business, keeping 12.2% of every revenue dollar as net income compared to CVX's 6.7%. On growth, SU holds the edge at +25.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $47.0B | $52.0B | $184.4B | $49.4B | $323.9B |
| EBITDAEarnings before interest/tax | $6.8B | $21.7B | $37.1B | $12.4B | $59.9B |
| Net IncomeAfter-tax profit | $3.3B | $6.3B | $12.3B | $4.6B | $28.8B |
| Free Cash FlowCash after capex | $4.7B | $7.2B | $16.2B | $4.4B | $23.6B |
| Gross MarginGross profit ÷ Revenue | +21.2% | +55.5% | +30.4% | +19.6% | +21.7% |
| Operating MarginEBIT ÷ Revenue | +9.0% | +27.4% | +9.0% | +14.0% | +10.5% |
| Net MarginNet income ÷ Revenue | +6.9% | +12.2% | +6.7% | +9.4% | +8.9% |
| FCF MarginFCF ÷ Revenue | +10.0% | +13.9% | +8.8% | +8.8% | +7.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.7% | +25.1% | -5.3% | -12.8% | -1.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -57.8% | +30.1% | -24.5% | +78.7% | -11.0% |
Valuation Metrics
SU leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 17.9x trailing earnings, SU trades at a 35% valuation discount to CVX's 27.5x P/E. On an enterprise value basis, SU's 5.1x EV/EBITDA is more attractive than IMO's 13.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $62.6B | $75.7B | $364.2B | $53.6B | $620.8B |
| Enterprise ValueMkt cap + debt − cash | $64.8B | $86.5B | $404.5B | $64.1B | $653.7B |
| Trailing P/EPrice ÷ TTM EPS | 26.50x | 17.93x | 27.53x | 18.06x | 21.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.96x | 7.73x | 15.02x | 7.47x | 14.79x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 12.96x | 5.13x | 10.89x | 8.91x | 10.91x |
| Price / SalesMarket cap ÷ Revenue | 1.81x | 2.11x | 1.97x | 1.47x | 1.92x |
| Price / BookPrice ÷ Book value/share | 3.89x | 2.35x | 1.76x | 2.24x | 2.37x |
| Price / FCFMarket cap ÷ FCF | 18.17x | 14.92x | 21.95x | 21.48x | 26.29x |
Profitability & Efficiency
Evenly matched — IMO and SU each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
CVE delivers a 15.2% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $7 for CVX. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVE's 0.54x. On the Piotroski fundamental quality scale (0–9), SU scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.7% | +14.0% | +7.2% | +15.2% | +10.7% |
| ROA (TTM)Return on assets | +8.1% | +7.0% | +4.2% | +7.8% | +6.4% |
| ROICReturn on invested capital | +12.3% | +20.1% | +6.2% | +7.9% | +8.6% |
| ROCEReturn on capital employed | +11.9% | +19.5% | +6.6% | +8.2% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 6 | 3 |
| Debt / EquityFinancial leverage | 0.19x | 0.41x | 0.24x | 0.54x | 0.16x |
| Net DebtTotal debt minus cash | $3.1B | $14.7B | $40.3B | $14.3B | $32.9B |
| Cash & Equiv.Liquid assets | $1.1B | $3.6B | $6.5B | $2.7B | $10.7B |
| Total DebtShort + long-term debt | $4.2B | $18.4B | $46.7B | $17.0B | $43.5B |
| Interest CoverageEBIT ÷ Interest expense | — | 11.68x | 17.22x | 11.80x | 69.44x |
Total Returns (Dividends Reinvested)
IMO leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IMO five years ago would be worth $42,567 today (with dividends reinvested), compared to $19,396 for CVX. Over the past 12 months, CVE leads with a +147.0% total return vs CVX's +39.5%. The 3-year compound annual growth rate (CAGR) favors IMO at 41.1% vs CVX's 8.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +42.0% | +40.8% | +18.2% | +63.2% | +20.3% |
| 1-Year ReturnPast 12 months | +87.1% | +92.7% | +39.5% | +147.0% | +43.9% |
| 3-Year ReturnCumulative with dividends | +180.9% | +128.8% | +26.7% | +85.3% | +44.9% |
| 5-Year ReturnCumulative with dividends | +325.7% | +201.0% | +94.0% | +286.8% | +164.6% |
| 10-Year ReturnCumulative with dividends | +337.2% | +197.4% | +135.8% | +118.2% | +105.0% |
| CAGR (3Y)Annualised 3-year return | +41.1% | +31.8% | +8.2% | +22.8% | +13.2% |
Risk & Volatility
Evenly matched — IMO and XOM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than IMO's 0.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IMO currently trades 93.7% from its 52-week high vs XOM's 83.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.25x | -0.03x | -0.05x | 0.22x | -0.15x |
| 52-Week HighHighest price in past year | $134.32 | $70.29 | $214.71 | $30.84 | $176.41 |
| 52-Week LowLowest price in past year | $67.50 | $33.50 | $133.77 | $11.60 | $101.19 |
| % of 52W HighCurrent price vs 52-week peak | +93.7% | +90.7% | +85.0% | +92.3% | +83.0% |
| RSI (14)Momentum oscillator 0–100 | 50.7 | 48.7 | 42.1 | 63.0 | 42.4 |
| Avg Volume (50D)Average daily shares traded | 663K | 4.6M | 11.0M | 13.1M | 18.9M |
Analyst Outlook
Evenly matched — IMO and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IMO as "Hold", SU as "Buy", CVX as "Buy", CVE as "Hold", XOM as "Hold". Consensus price targets imply 9.5% upside for XOM (target: $160) vs -64.2% for IMO (target: $45). For income investors, CVX offers the higher dividend yield at 3.76% vs IMO's 1.62%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $44.99 | $62.00 | $190.93 | $27.67 | $160.43 |
| # AnalystsCovering analysts | 20 | 31 | 53 | 27 | 55 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | +2.6% | +3.8% | +2.0% | +2.7% |
| Dividend StreakConsecutive years of raises | 27 | 4 | 8 | 0 | 26 |
| Dividend / ShareAnnual DPS | $2.78 | $2.30 | $6.87 | $0.78 | $4.00 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.8% | +3.0% | +3.3% | +3.4% | +3.3% |
SU leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). IMO leads in 1 (Total Returns). 3 tied.
IMO vs SU vs CVX vs CVE vs XOM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IMO or SU or CVX or CVE or XOM a better buy right now?
For growth investors, Suncor Energy Inc.
(SU) is the stronger pick with -3. 5% revenue growth year-over-year, versus -14. 0% for Cenovus Energy Inc. (CVE). Suncor Energy Inc. (SU) offers the better valuation at 17. 9x trailing P/E (7. 7x forward), making it the more compelling value choice. Analysts rate Suncor Energy Inc. (SU) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IMO or SU or CVX or CVE or XOM?
On trailing P/E, Suncor Energy Inc.
(SU) is the cheapest at 17. 9x versus Chevron Corporation at 27. 5x. On forward P/E, Cenovus Energy Inc. is actually cheaper at 7. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IMO or SU or CVX or CVE or XOM?
Over the past 5 years, Imperial Oil Limited (IMO) delivered a total return of +325.
7%, compared to +94. 0% for Chevron Corporation (CVX). Over 10 years, the gap is even starker: IMO returned +337. 2% versus XOM's +105. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IMO or SU or CVX or CVE or XOM?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Imperial Oil Limited's 0. 25β — meaning IMO is approximately -269% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 54% for Cenovus Energy Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IMO or SU or CVX or CVE or XOM?
By revenue growth (latest reported year), Suncor Energy Inc.
(SU) is pulling ahead at -3. 5% versus -14. 0% for Cenovus Energy Inc. (CVE). On earnings-per-share growth, the picture is similar: Cenovus Energy Inc. grew EPS 28. 7% year-over-year, compared to -31. 8% for Chevron Corporation. Over a 3-year CAGR, SU leads at -5. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IMO or SU or CVX or CVE or XOM?
Suncor Energy Inc.
(SU) is the more profitable company, earning 12. 1% net margin versus 6. 7% for Chevron Corporation — meaning it keeps 12. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SU leads at 31. 7% versus 8. 8% for CVE. At the gross margin level — before operating expenses — SU leads at 59. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IMO or SU or CVX or CVE or XOM more undervalued right now?
On forward earnings alone, Cenovus Energy Inc.
(CVE) trades at 7. 5x forward P/E versus 15. 0x for Chevron Corporation — 7. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XOM: 9. 5% to $160. 43.
08Which pays a better dividend — IMO or SU or CVX or CVE or XOM?
All stocks in this comparison pay dividends.
Chevron Corporation (CVX) offers the highest yield at 3. 8%, versus 1. 6% for Imperial Oil Limited (IMO).
09Is IMO or SU or CVX or CVE or XOM better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Both have compounded well over 10 years (XOM: +105. 0%, CVE: +118. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IMO and SU and CVX and CVE and XOM?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IMO is a mid-cap quality compounder stock; SU is a mid-cap deep-value stock; CVX is a large-cap income-oriented stock; CVE is a mid-cap quality compounder stock; XOM is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.